Recent EBS News
- Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development • GlobeNewswire Inc. • 11/04/2024 12:30:00 PM
- Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024 • GlobeNewswire Inc. • 10/23/2024 11:30:55 AM
- Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic • GlobeNewswire Inc. • 10/08/2024 09:32:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 11:29:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 12:11:30 PM
- Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility • GlobeNewswire Inc. • 10/02/2024 11:30:00 AM
- Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts • GlobeNewswire Inc. • 09/26/2024 12:05:00 PM
- Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts • GlobeNewswire Inc. • 09/25/2024 11:07:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:12:31 PM
- Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation • GlobeNewswire Inc. • 09/13/2024 10:45:00 AM
- Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola • GlobeNewswire Inc. • 09/12/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 11:47:30 AM
- Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile • GlobeNewswire Inc. • 09/03/2024 11:08:45 AM
- Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness • GlobeNewswire Inc. • 08/30/2024 12:16:09 PM
- Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions • GlobeNewswire Inc. • 08/29/2024 10:53:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:20:43 PM
- Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals • GlobeNewswire Inc. • 08/20/2024 03:30:55 PM
- Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa • GlobeNewswire Inc. • 08/19/2024 09:10:37 PM
- Emergent BioSolutions Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/06/2024 09:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:34:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:21:53 PM
- Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country • GlobeNewswire Inc. • 08/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 12:56:36 PM
- Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million • GlobeNewswire Inc. • 07/31/2024 12:53:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:30:51 PM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM